Ashfield Capital Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-43,412
| Closed | -$4.31M | – | 238 |
|
|
2019
Q3 | $4.31M | Sell |
43,412
-536
| -1% | -$50.9K | 0.47% | 61 |
|
|
2019
Q2 | $4.06M | Sell |
43,948
-897
| -2% | -$85.2K | 0.43% | 67 |
|
|
2019
Q1 | $4.23M | Buy |
44,845
+2,509
| +6% | +$219K | 0.46% | 64 |
|
|
2018
Q4 | $2.71M | Sell |
42,336
-4,300
| -9% | -$317K | 0.35% | 76 |
|
|
2018
Q3 | $4.17M | Sell |
46,636
-962
| -2% | -$85K | 0.47% | 63 |
|
|
2018
Q2 | $3.78M | Sell |
47,598
-2,295
| -5% | -$191K | 0.47% | 63 |
|
|
2018
Q1 | $4.45M | Sell |
49,893
-18,411
| -27% | -$1.77M | 0.58% | 50 |
|
|
2017
Q4 | $7.13M | Sell |
68,304
-1,391
| -2% | -$157K | 0.92% | 33 |
|
|
2017
Q3 | $10.2M | Sell |
69,695
-3,037
| -4% | -$414K | 1.36% | 17 |
|
|
2017
Q2 | $9.45M | Buy |
72,732
+192
| +0.3% | +$23.5K | 1.29% | 17 |
|
|
2017
Q1 | $9.03M | Sell |
72,540
-52,521
| -42% | -$6.29M | 1.25% | 20 |
|
|
2016
Q4 | $14.5M | Sell |
125,061
-27,469
| -18% | -$3.06M | 1.42% | 17 |
|
|
2016
Q3 | $15.9M | Sell |
152,530
-14,249
| -9% | -$1.54M | 1.31% | 20 |
|
|
2016
Q2 | $16.4M | Sell |
166,779
-33,057
| -17% | -$3.42M | 1.32% | 25 |
|
|
2016
Q1 | $20M | Sell |
199,836
-23,373
| -10% | -$2.41M | 1.45% | 22 |
|
|
2015
Q4 | $26.7M | Sell |
223,209
-56,358
| -20% | -$6.52M | 1.83% | 13 |
|
|
2015
Q3 | $30.2M | Sell |
279,567
-84,241
| -23% | -$10.5M | 1.94% | 9 |
|
|
2015
Q2 | $42.1M | Sell |
363,808
-11,361
| -3% | -$1.3M | 2.31% | 5 |
|
|
2015
Q1 | $43.2M | Sell |
375,169
-73,751
| -16% | -$8.81M | 2.3% | 4 |
|
|
2014
Q4 | $50.2M | Sell |
448,920
-11,095
| -2% | -$1.17M | 2.43% | 6 |
|
|
2014
Q3 | $43.6M | Sell |
460,015
-13,546
| -3% | -$1.22M | 2.12% | 6 |
|
|
2014
Q2 | $40.7M | Sell |
473,561
-16,511
| -3% | -$1.26M | 1.91% | 10 |
|
|
2014
Q1 | $34.2M | Sell |
490,072
-9,938
| -2% | -$787K | 1.65% | 20 |
|
|
2013
Q4 | $42.2M | Sell |
500,010
-10,058
| -2% | -$796K | 2.02% | 7 |
|
|
2013
Q3 | $39.3M | Sell |
510,068
-34,478
| -6% | -$2.42M | 2.03% | 5 |
|
|
2013
Q2 | $31.9M | Buy |
+544,546
| New | +$32.8M | 1.72% | 11 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Ashfield Capital Partners's CELG Position: Q4 2019 in Review
Ashfield Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 43,412 shares — an estimated $4.31M sold.
Ashfield Capital Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $50.2M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Ashfield Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Ashfield Capital Partners sold 43,412 Celgene Corp shares in Q4 2019, an estimated $4.31M.
- Ashfield Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Ashfield Capital Partners's Celgene Corp position peaked at $50.2M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Ashfield Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.